Mechanical Circulatory Support Devices
Peer reviewed
Scollr summary
What this paper is about
Baseline LDH alone is not a reliable predictor of pump thrombosis, and this dynamic surge serves as a practical, device-independent decision-support tool to rule out pump thrombosis with high confidence in all cf-LVAD patients.
Full abstract
Read the full abstract
Objective: To determine the incidence of intravascular hemolysis in patients implanted with continuous-flow left ventricular assist devices (LVADs), to describe longitudinal changes in hemolysis-related laboratory markers (LDH, total/direct bilirubin, INR), and to assess their diagnostic value for pump thrombosis and cerebrovascular events. Methods: We retrospectively analyzed 100 end-stage heart failure patients (2014–2015). To ensure consistent longitudinal analysis, 59 long-term survivors (42 HeartWare HVAD, 17 HeartMate II) were included. For each patient, a dynamic LDH increase ratio (peak/preoperative baseline) was calculated. The diagnostic performance of the criterion “LDH >250 U/L and ⩾4-fold increase from baseline” was evaluated. Cox regression, ROC analysis, and Kaplan–Meier survival analysis were performed. Results: During 1-year follow-up, 17 patients experienced thrombotic or cerebrovascular events (8 confirmed pump thrombosis). While absolute LDH values at fixed time points were not discriminative, the dynamic LDH increase ratio was significantly higher in the thrombosis group ( p = 0.0102), with an AUC of 0.840. Preoperative LDH was a significant risk factor in Cox regression (HR: 1.005, p = 0.009), reflecting baseline disease severity. The ⩾4-fold LDH increase criterion demonstrated a Negative Predictive Value (NPV) of 97.6%, indicating excellent rule-out performance. No significant difference was found between device types ( p > 0.05), supporting a device-independent biomarker dynamic. Conclusion: Baseline LDH alone is not a reliable predictor of pump thrombosis. In contrast, a ⩾4-fold dynamic rise in LDH relative to the patient’s own baseline provides excellent negative predictive value. This dynamic surge serves as a practical, device-independent decision-support tool to rule out pump thrombosis with high confidence in all cf-LVAD patients.
Direct answer
What can I do from this paper page?
Use this page to scan "Intravascular hemolysis and clinical outcomes in continuous-flow LVAD patients: A single-center retrospective analysis" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Mechanical Circulatory Support Devices research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Kl2026Intravascular,
title = {Intravascular hemolysis and clinical outcomes in continuous-flow LVAD patients: A single-center retrospective analysis},
author = {Ali Kılıç and Çağatay Engin and Tahir Yağdı and Mustafa Özbaran},
journal = {The International Journal of Artificial Organs},
year = {2026},
doi = {10.1177/03913988261479983},
url = {https://doi.org/10.1177/03913988261479983}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Mechanical Circulatory Support Devices research papers?
Follow Mechanical Circulatory Support Devices research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Intravascular hemolysis and clinical outcomes in continuous-flow LVAD patients: A single-center retrospective analysis. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app